ALICIA WHITWELL: Open Payments
NPI 1174602221 · DESLOGE, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,089 in 66 payments from 23 companies in 2025. Trend: 2023 $543 · 2024 $679 · 2025 $1,089
Food & beverage: $1,089
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 28 | $372 |
| Otsuka America Pharmaceutical, Inc. | 4 | $78 |
| Lilly USA, LLC | 3 | $62 |
| Merck Sharp & Dohme LLC | 3 | $61 |
| Aimmune Therapeutics, Inc. | 3 | $49 |
| Novo Nordisk Inc | 3 | $44 |
| Janssen Pharmaceuticals, Inc | 2 | $43 |
| Novartis Pharmaceuticals Corporation | 2 | $42 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $38 |
| Verona Pharma, Inc. | 2 | $33 |
Products named: QULIPTA, VRAYLAR, REXULTI, UBRELVY, MOUNJARO, ZENPEP, CREON, SPRAVATO.
Industry payments across MO — which companies pay providers there.
